You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ALKS Sale Disclosure
Hopkinson Craig C. · SEC Form 4 · Filed Jul 1, 2026
Sale
Calculated transaction value
$427.13K
Hopkinson Craig C. EVP R&d, Chief Medical Officer
ALKS
Alkermes Inc
ALKS
Transaction date
Jul 1, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed same day
ALKS daily price context
Close on/before transaction
$51.72
Jul 1, 2026
First close after public filing
$54.58
Jul 2, 2026
30-day return after filing
-10.24%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 8,300 shares @ $51.46
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001520262-26-000103
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$560.32K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Alkermes Plc. ALKS | Exercise | Jul 1, 2026 | $96.7K |
| Alkermes Plc. ALKS Current | Sale | Jul 1, 2026 | $427.13K |
| Alkermes Plc. ALKS | Sale | Jul 1, 2026 | $36.49K |
| Alkermes Plc. ALKS | Exercise | Jul 1, 2026 | $0 |